Graham Crawley

Response by Commission on Human Medicines to Graham Crawley on 1 November 2022.

Refused.

Internal Review of FOI 22/937 Dear Mr Crawley, Thank you for your email. Please find attached the response to your Internal Review re...

More Covid-19 vaccine deaths than expected compared with deaths from influenza vaccines

Response by Medicines and Healthcare Products Regulatory Agency to Graham Crawley on 4 August 2022.

Awaiting internal review.

CEC 97680 Dear Mr Crawley, Thank you for your email. To confirm your enquiry is not being treated under FOI as the request is not seeking recorded i...

Deaths following influenza vaccination

Response by Medicines and Healthcare Products Regulatory Agency to Graham Crawley on 21 April 2022.

Partially successful.

Dear Mr Crawley, Please find attached a response to your FOI request. Kind regards, FOI Team Vigilance and Risk Management of Medic...

Nuvaxovid pharmacokinetics

Response by Medicines and Healthcare Products Regulatory Agency to Graham Crawley on 7 April 2022.

Information not held.

Internal Review of FOI 22/451 Dear Graham Crawley, Thank you for your patience whilst we conducted our internal review. We do not think the public i...

Covid-19 vaccines and atrial fibrillation

Response by Medicines and Healthcare Products Regulatory Agency to Graham Crawley on 17 February 2022.

Information not held.

Dear Graham Crawley, Please find attached a response to your FOI request. Kind regards, FOI Team Vigilance and Risk Management of Medicines Division...

Auto-immune like pathology following vaccination for Covid-19

Response by Medicines and Healthcare Products Regulatory Agency to Graham Crawley on 24 January 2022.

Refused.

Dear Mr Crawley, Please find attached the response to your FOI request. Kind regards, FOI Team Vigilance and Risk Management of Medicines D...

How many deaths are too many with Pfizer BNT162B2 in order to halt deployment?

Response by Medicines and Healthcare Products Regulatory Agency to Graham Crawley on 7 January 2022.

Refused.

Dear Enquirer Thank you for your email. The Medicines and Healthcare products Regulatory Agency’s (MHRA’s) role is to continually monitor...

Microbubble polymers in J&J COVID-19 vaccine

Response by Medicines and Healthcare Products Regulatory Agency to Graham Crawley on 25 October 2021.

Refused.

Dear Mr Crawley Regarding the questions in your request of 16 October 2021, please see below MHRA’s response. 1. Will you confirm that mi...

Oxford/Astrazeneca vaccine ChAdOx1-S [recombinant]: toxicolgy and pharmacodynamics

Response by Medicines and Healthcare Products Regulatory Agency to Graham Crawley on 2 August 2021.

Information not held.

Dear Mr Crawley Thank you for your email. A response was sent below to you on 7 July. Yours sincerely MHRA Customer Service Centre Medicines...

COVID-19 Pfizer/BioNTech mRNA Vaccine BNT162b2: toxicolgy and pharmacodynamics

Response by Medicines and Healthcare Products Regulatory Agency to Graham Crawley on 2 August 2021.

Information not held.

Dear Mr Crawley, Thank you for your email. Please find attached response that was sent on 7 July. Kind Regards MHRA Customer Service Centre Medic...

MHRA staff Covid vaccines uptake

Response by Medicines and Healthcare Products Regulatory Agency to Graham Crawley on 23 July 2021.

Information not held.

Dear Graham Crawley, Thank you for your email, please see below for our response. Q1. Dear Medicines and Healthcare Products Regulatory Agency, How m...

Covid 19 vaccine adverse reactions in people taking methotrexate

Response by Medicines and Healthcare Products Regulatory Agency to Graham Crawley on 28 June 2021.

Information not held.

Dear Mr Crawley, Please find attached the response to your FOI request. Kind regards, FOI Team Vigilance and Risk Management of Medicines D...

Covid 19 vaccine adverse reactions in people on anti-coagulants

Response by Medicines and Healthcare Products Regulatory Agency to Graham Crawley on 28 June 2021.

Information not held.

Dear Mr Crawley, Please find attached the response to your FOI request. Kind regards, FOI Team Vigilance and Risk Management of Medicines Division...

Covid 19 vaccine adverse reactions in people taking TNF inhibitors

Response by Medicines and Healthcare Products Regulatory Agency to Graham Crawley on 28 June 2021.

Information not held.

Dear Mr Crawley, Please find attached the response to your FOI request. Kind regards, FOI Team Vigilance and Risk Management of Medicines D...

WhatDoTheyKnow

Track this person

On this page

This person's Freedom of Information requests (approximately 14)

This person's annotations

WhatDoTheyKnow